amiodarone has been researched along with Adverse Effects, Long Term in 3 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) randomized 2,521 patients with moderate heart failure (HF) to amiodarone, placebo drug, or implantable cardioverter-defibrillator (ICD) therapy." | 5.34 | Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT. ( Anderson, J; Anstrom, KJ; Bardy, GH; Boineau, RE; Davidson-Ray, L; Fishbein, DP; Hellkamp, AS; Johnson, G; Lee, KL; Mark, DB; Olshansky, B; Packer, DL; Poole, JE; Reinhall, PG, 2020) |
| "Guidelines for treatment of out-of-hospital cardiac arrest (OOH-CA) with shockable rhythm recommend amiodarone, while lidocaine may be used if amiodarone is not available." | 4.93 | Amiodarone or lidocaine for cardiac arrest: A systematic review and meta-analysis. ( Arcadipane, A; Corredor, C; Panarello, G; Pellis, T; Ristagno, G; Sanfilippo, F; Santonocito, C, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Poole, JE | 1 |
| Olshansky, B | 1 |
| Mark, DB | 1 |
| Anderson, J | 1 |
| Johnson, G | 1 |
| Hellkamp, AS | 1 |
| Davidson-Ray, L | 1 |
| Fishbein, DP | 1 |
| Boineau, RE | 1 |
| Anstrom, KJ | 1 |
| Reinhall, PG | 1 |
| Packer, DL | 1 |
| Lee, KL | 1 |
| Bardy, GH | 1 |
| Dalgaard, F | 1 |
| Pallisgaard, JL | 1 |
| Lindhardt, TB | 1 |
| Torp-Pedersen, C | 1 |
| Gislason, GH | 1 |
| Ruwald, MH | 1 |
| Sanfilippo, F | 1 |
| Corredor, C | 1 |
| Santonocito, C | 1 |
| Panarello, G | 1 |
| Arcadipane, A | 1 |
| Ristagno, G | 1 |
| Pellis, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sudden Cardiac Death in Heart Failure Trial 10 Year Follow-up (SCD-HeFT 10 Year)[NCT01058837] | 1,855 participants (Anticipated) | Observational | 2009-09-30 | Active, not recruiting | |||
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for amiodarone and Adverse Effects, Long Term
| Article | Year |
|---|---|
Amiodarone or lidocaine for cardiac arrest: A systematic review and meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Hospitalization; Humans; Lidocain | 2016 |
1 trial available for amiodarone and Adverse Effects, Long Term
| Article | Year |
|---|---|
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Elect | 2020 |
1 other study available for amiodarone and Adverse Effects, Long Term
| Article | Year |
|---|---|
Rate and rhythm therapy in patients with atrial fibrillation and the risk of pacing and bradyarrhythmia.
Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Denmark; Fe | 2019 |